Bill Sibold, Madrigal Pharmaceuticals CEO, joins ‘Fast Money’ to discuss Q2 earnings results, the weight loss space and their GLP-1 strategy.
Source link
Trending
- These are the most overbought stocks in the market, including Apple and Alphabet
- America’s dying shopping mall has a surprise recovery in store
- The S&P 500 is on the cusp of another record. How long can this bull keep dodging danger?
- Crypto may be coming to 401(k)s, but it’ll be a while before savers can jump in
- Cash’s decline gives buskers the blues, but apps keep the green flowing
- Restaurants like Starbucks, Smoothie King seek to join protein trend
- Activist Carronade spots a hidden gem in Viasat’s business. How the firm may unlock value
- Using buy now, pay later loans for concert tickets
Madrigal Pharmaceuticals CEO: We're positioned for decades of growth
